title: [Cardiogenic shock after drug therapy for atrial fibrillation with tachycardia : Case report of an 89-year-old woman].
abstract: β-Blockers and calcium channel blockers are commonly used drugs in the treatment of atrial fibrillation with tachycardia. However, in patients with high myocardial susceptibility and vulnerability, combination therapy with β-blockers and non-dihydropyridine calcium channel blockers (verapamil or diltiazem) but also individual administration can cause drug-induced cardiogenic shock. Thus, the simultaneous administration of β-blockers and non-dihydropyridine calcium channel blockers is absolutely contraindicated. In case of acute heart failure, isolated application is also contraindicated. In the treatment of a cardiogenic shock induced by β-blockers and/or non-dihydropyridine calcium channel blockers, administration of intravenous calcium, glucagon or high-dose insulin is recommended.
authors.affiliation: Universitätsklinik für Notfall- und Internistische Intensivmedizin, Paracelsus Medizinische Privatuniversität, Nürnberg, Klinikum Nürnberg, Prof. Ernst Nathan Str. 1, 90419, Nürnberg, Deutschland. aufnahme@klinikum-nuernberg.de.
authors.forename: H
authors.initials: H
authors.lastname: Fey
authors.affiliation: Universitätsklinik für Notfall- und Internistische Intensivmedizin, Paracelsus Medizinische Privatuniversität, Nürnberg, Klinikum Nürnberg, Prof. Ernst Nathan Str. 1, 90419, Nürnberg, Deutschland.
authors.forename: M
authors.initials: M
authors.lastname: Jost
authors.affiliation: Universitätsklinik für Notfall- und Internistische Intensivmedizin, Paracelsus Medizinische Privatuniversität, Nürnberg, Klinikum Nürnberg, Prof. Ernst Nathan Str. 1, 90419, Nürnberg, Deutschland.
authors.forename: A T
authors.initials: AT
authors.lastname: Geise
authors.affiliation: Institut für Klinische Chemie, Laboratoriumsmedizin und Transfusionsmedizin - Zentrallaboratorium, Paracelsus Medizinische Privatuniversität, Nürnberg, Nürnberg, Deutschland.
authors.forename: T
authors.initials: T
authors.lastname: Bertsch
authors.affiliation: Universitätsklinik für Notfall- und Internistische Intensivmedizin, Paracelsus Medizinische Privatuniversität, Nürnberg, Klinikum Nürnberg, Prof. Ernst Nathan Str. 1, 90419, Nürnberg, Deutschland.
authors.forename: M
authors.initials: M
authors.lastname: Christ
mesh_terms: D000369:Aged, 80 and over; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002227:Carbazoles / Q000009:adverse effects* / Q000627:therapeutic use*; D000077261:Carvedilol; D003422:Critical Care / Q000379:methods*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D011412:Propanolamines / Q000009:adverse effects* / Q000627:therapeutic use*; D012770:Shock, Cardiogenic / Q000139:chemically induced*; D013610:Tachycardia / Q000188:drug therapy*; D014700:Verapamil / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol; D014700:Verapamil
keywords: Beta-blockers, adrenergic; Calcium channel blockers; Cardiac dysrhythmia; Glucagon; Tachycardia